United States Cytomegalovirus Infection Treatment Market 2025 | Growth Drivers, Competitive Landscape & Expansion Trends & Market Forecast

Market Size and Growth

The Global Cytomegalovirus Infection Treatment Market reached US$ 516.36 million in 2023 and is expected to reach US$ 858.65 million by 2031, growing at a CAGR of 6.7% during the forecast period 2024-2031.

Recent Mergers and acquisitions:

United States: Recent M&A Developments in CMV Treatment

✅ In February 2024, AstraZeneca completed the acquisition of Gracell Biotechnologies, a clinical-stage biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This acquisition may influence CMV treatment approaches by integrating advanced cell therapy technologies.

✅ In October 2024, Merck completed the acquisition of CN201, an investigational B-cell depletion therapy from Curon Biopharmaceutical. This strategic move strengthens Merck's immunology pipeline and expands its potential applications in transplant-related complications, reflecting a shift towards immunomodulatory therapies in CMV management.

Japan: Recent M&A Developments in CMV Treatment

✅ In October 2024, Chimerix announced a partnership with a Japanese pharmaceutical company to develop and commercialize its antiviral therapies targeting CMV. This partnership expands Chimerix's reach into the Japanese market, enhancing global access to CMV treatments.

✅ In August 2024, Takeda entered into a strategic partnership with VBI Vaccines to co-develop and commercialize VBI's CMV vaccine candidate. This collaboration aims to advance preventive therapies for CMV, complementing existing antiviral treatments.

✅ In June 2024, Takeda announced the approval of Maribavir in Japan for the treatment of post-transplant CMV infection/disease that is refractory to existing anti-CMV therapies. This approval provides a new treatment option for patients in Japan, addressing a significant unmet medical need.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cytomegalovirus-infection-treatment-market?sb

Cytomegalovirus Infection Treatment involves the use of antiviral medications such as ganciclovir, valganciclovir, foscarnet, or cidofovir to manage CMV infections, especially in immunocompromised patients. Treatment aims to suppress viral replication, prevent organ damage, reduce complications, and improve patient outcomes.

Key Players:

=> Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Fresenius Kabi Canada, GSK Plc, AiCuris Anti-infective Cures AG, Chimerix, Inc., Abbott, Bio-Rad Laboratories, Inc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd among others.

Growth Forecast Projected:

The Global Cytomegalovirus Infection Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Cytomegalovirus Infection Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cytomegalovirus-infection-treatment-market

Key Segments:

➥ By Drug Type: Cytovene, Valcyte, Foscarnet, Vistide, Others
➥ By Application: Stem Cell Transplantation, Organ Transplantation, Congenital CMV Infection, Others
➥ By Infection: Retinitis, Pneumonia, Esophagitis, Colitis, Others
➥ By Diagnosis Test: Serologic Test, Polymerase Chain Reaction (PCR) Test, Others
➥ By Route of Administration: Oral, Intravenous
➥ By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
➥ By End-User: Hospitals, Specialty Clinics, Homecare, Others

Regional Analysis for Cytomegalovirus Infection Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Cytomegalovirus Infection Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Cytomegalovirus Infection Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cytomegalovirus-infection-treatment-market?sb

FAQ

What is the current size of the Cytomegalovirus Infection Treatment Market?

A: In 2023, the Cytomegalovirus Infection Treatment Market was valued at US$ 516.36 million, reflecting its strong industry presence.

Q2: How large is the Cytomegalovirus Infection Treatment Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Cytomegalovirus Infection Treatment Market will grow to around US$ 858.65 million , demonstrating significant expansion.

Q3: What is the growth rate of the Cytomegalovirus Infection Treatment Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.